BRIEF published on 06/30/2026 at 02:05, 1 month 10 days ago Analyse financière de MedMira pour le troisième trimestre de l'exercice 2026 et efforts d'expansion sur le marché Résultats Trimestriels Approbation Réglementaire Expansion Du Marché Test De Dépistage De La Syphilis Données Financières De MedMira
BRIEF published on 06/30/2026 at 02:05, 1 month 10 days ago MedMira's Q3 FY2026 Financial Review and Market Expansion Efforts Regulatory Approval Market Expansion Quarterly Results Syphilis Test MedMira Financials
PRESS RELEASE published on 06/30/2026 at 02:00, 1 month 10 days ago MedMira Reports Third Quarter Results FY2026 MedMira Inc. (TSXV:MIR) reports on Q3 FY2026 financial results, advances regulatory process for Multiplo® Complete Syphilis Antibody Test, and increases international market interest Financial Results Regulatory Approval MedMira Inc. International Markets Rapid Diagnostic Tests
BRIEF published on 04/02/2026 at 04:05, 4 months 8 days ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
BRIEF published on 04/02/2026 at 04:05, 4 months 8 days ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
PRESS RELEASE published on 04/02/2026 at 04:00, 4 months 8 days ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 7 months 10 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 7 months 10 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 7 months 10 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 8 months 11 days ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
Published on 08/10/2026 at 15:30, 1 hour 34 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 1 hour 39 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 2 hours 34 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 3 hours 34 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 4 hours 4 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 15:56, 1 hour 8 minutes ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 15:44, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/10/2026 at 15:43, 1 hour 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/10/2026 at 11:53, 5 hours 10 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 5 hours 10 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 5 hours 27 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 11:36, 5 hours 27 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Published on 08/10/2026 at 09:47, 7 hours 17 minutes ago 260810 BENETEAU Transactions sur actions propres
